(Date:11/6/2009)...ROOK, N.Y., Nov. 6 BioSp...pharmaceutical company developing first-in-class c...ancial results for the third quarter ended Septemb... in September of this year, the FDA,s Arthritis Ad...e of 12-0, the approval of XIAFLEX(TM) for the tre...
(Date:11/6/2009)...MATEO, Calif., Nov. 6 ,...ed transfer of Qutenza(TM) E.U. Marketing Authoriz...icant progress in commercial readiness activities ...ior Director, Marketing; and Director, Commercial ... as director and Audit Committee chairman , ...
(Date:11/6/2009)... The agenda for Arrowhead’s 2... which is set to take place on February 22-24, 201...ee day conference we will highlight key issues in ...to share their experiences. , ...he agenda for Arrowhead’s 2010 Personalized...
(Date:11/5/2009)...IPPANY, N.J., Nov. 5 DSM Pharmaceu...manufacturing alliance with Galenix, Saint Jean D,...mercial scale manufacturing partner for Galenix co... Galenix will collaborate on business development ...echnologies, based on the strength of Galenix in d...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3... May 12 WaferGen Biosystems,Inc. (OTC Bulletin Bo...t,gene expression, genotyping, cell biology and st...Alnoor Shivji, President and Chief Executive,Offic...odman & Renshaw,Fifth Annual Global Healthcare Con...08, at the Le Meridien Beach Plaza Hotel in Monte ...
...f., May 9 Bionovo, Inc.,(Nasdaq: BNVI ) today an...uarter Results, The company did not report any re...evenues for the three months ended March 31, 2007 ...logy transfer agreement with United,Biotechnology ...inated the,agreement following notice of material ...
... May 9 Alexion,Pharmaceuticals, Inc. (Nasdaq: AL...esentation at the Bank of America 2008 Health Care...p.m., local time (7:00 p.m., eastern),on Tuesday, ...nd Chief,Financial Officer, is scheduled to presen...be available live. You can,access the webcast at: ...
Other Biology Technology:WaferGen to Present at the Rodman and Renshaw Fifth Annual Global Healthcare Conference 2Bionovo Reports First Quarter 2008 Financial Results 2Bionovo Reports First Quarter 2008 Financial Results 3Bionovo Reports First Quarter 2008 Financial Results 4Bionovo Reports First Quarter 2008 Financial Results 5Bionovo Reports First Quarter 2008 Financial Results 6...300 (YELLOW), 1 EA. Ultrospec 6300 pro UV/Visibl...ements of the Pharmacopoeia in terms of instrument...benefits of being able to be used for rapid, discr...ent scanning capability., *Press to read high perf...
Cy3 Ab Labeling Kit from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-NPM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
QuantiChrom Zinc Assay Kit from BioAssay Systems
Biology Products: